Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-30 @ 11:11 PM
Study NCT ID:
NCT04935268
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2021-06-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Demographic Differences in Patients With Abdominal Aortic Aneurysm and Surgical Features of Treatment
Sponsor:
Ryazan State Medical University
Organization:
Study Overview
Official Title:
Demographic Differences in Patients With Abdominal Aortic Aneurysm and Surgical Features of Treatment
Status:
COMPLETED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study of demographics and risk factors for abdominal aortic aneurysms, allows to individualize treatment approaches.
Determining of the results of treatment of patients who requires a late open conversion after EVAR will allow to develop the surgical approach and the selection of the optimal type of surgical treatment.
Determination of genetic polymorphisms will reduce the number of postoperative complications by predicting of possible complications in the long term period.
Determining of the results of treatment of patients who requires a late open conversion after EVAR will allow to develop the surgical approach and the selection of the optimal type of surgical treatment.
Determination of genetic polymorphisms will reduce the number of postoperative complications by predicting of possible complications in the long term period.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: